4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shanghai HeartCare Medical Technology Corporation Limited (6609) operates in the Medical Devices industry and is headquartered in Shanghai, China with about 367 employees. Its market capitalization is roughly CNY 2 billion. In the fiscal year ended 2025-12-31, 6609 reported CNY 408M in revenue and CNY 83M in net income.
Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices in Mainland China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 408M | CNY 278M | CNY 232M | CNY 183M | — |
| Gross Profit | CNY 290M | CNY 182M | CNY 164M | CNY 124M | — |
| Operating Income (EBIT) | CNY 78M | (CNY 6M) | (CNY 103M) | (CNY 186M) | — |
| Net Income | CNY 83M | (CNY 14M) | (CNY 94M) | (CNY 200M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.2B | CNY 1.2B | CNY 1.3B | — |
| Total Liabilities | CNY 160M | CNY 144M | CNY 126M | CNY 147M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6609 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms